GlaxoSmithKline hope to offer first inoculations in 2022
In the UK, GlaxoSmithKline is beginning a trial of a new combined Covid vaccine involving 4,000 people.
The British drugs giant has teamed up with South Korean pharmaceutical firm SK Bioscience.
GSK is hoping to offer vaccinations in the first half of 2022, if results are positive.
#News for #investors and #media: We’ve just announced the start of a Phase 3 clinical trial for an adjuvanted #COVID19 vaccine candidate we’re co-developing with SK bioscience. Find out more about our response to COVID-19: https://t.co/xbd8I3Mmqh pic.twitter.com/8plipJ8mov
— GSK (@GSK) August 31, 2021

Social Media Could Change Forever If Meta Loses US Legal Battle, Says Experts
Efforts To Achieve Peace Plan For Gaza Continue As US Meet Middle East Mediators
US Military Fire On Ship In Gulf Of Oman
Over 250 People Now Confirmed Dead Following Devastating Earthquake In Colombia
Rescue Operation Continues After 160 Dead In Colombian Earthquake
Six Killed In School Shooting Near Bangkok In Thailand
Reports Of Iran And Oman Working Towards Deal To Reopen Strait Of Hormuz
EU Home Affairs Ministers Meet To Discuss Protection Of Borders From Illegal Migration